BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15220369)

  • 1. Lack of lymphangiogenesis during breast carcinogenesis.
    Vleugel MM; Bos R; van der Groep P; Greijer AE; Shvarts A; Stel HV; van der Wall E; van Diest PJ
    J Clin Pathol; 2004 Jul; 57(7):746-51. PubMed ID: 15220369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
    Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
    J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
    Williams CS; Leek RD; Robson AM; Banerji S; Prevo R; Harris AL; Jackson DG
    J Pathol; 2003 Jun; 200(2):195-206. PubMed ID: 12754740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
    Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Node status in 454 ductal breast cancers cases according to the association with in situ component].
    Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J
    Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications.
    Mohammed RA; Ellis IO; Elsheikh S; Paish EC; Martin SG
    Breast Cancer Res Treat; 2009 Jan; 113(2):261-73. PubMed ID: 18293084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
    Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangiogenesis does not occur in breast cancer.
    Agarwal B; Saxena R; Morimiya A; Mehrotra S; Badve S
    Am J Surg Pathol; 2005 Nov; 29(11):1449-55. PubMed ID: 16224211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S; Wei B; Zhang H; Qing M; Bu H
    Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
    Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast.
    Gong Y; Sun X; Huo L; Wiley EL; Rao MS
    Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
    Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.
    van der Schaft DW; Pauwels P; Hulsmans S; Zimmermann M; van de Poll-Franse LV; Griffioen AW
    Cancer Lett; 2007 Aug; 254(1):128-36. PubMed ID: 17442484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of class 3 semaphorins and their receptors in human breast neoplasia.
    Staton CA; Shaw LA; Valluru M; Hoh L; Koay I; Cross SS; Reed MW; Brown NJ
    Histopathology; 2011 Aug; 59(2):274-82. PubMed ID: 21884206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
    Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
    J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stages on the way to breast cancer.
    Going JJ
    J Pathol; 2003 Jan; 199(1):1-3. PubMed ID: 12474219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.
    Shen D; Nooraie F; Elshimali Y; Lonsberry V; He J; Bose S; Chia D; Seligson D; Chang HR; Goodglick L
    Hum Pathol; 2006 Dec; 37(12):1583-91. PubMed ID: 16949910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
    de la Torre NG; Buley I; Wass JA; Turner HE
    Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinoma.
    Fernandez-Aguilar S; Jondet M; Simonart T; Nöel JC
    Breast; 2006 Dec; 15(6):782-5. PubMed ID: 16931017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Trinh XB; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    J Pathol; 2007 Sep; 213(1):56-64. PubMed ID: 17674348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.